Join us on Thursday, August 19th, 2021 at the beautiful Elbow Springs Golf Club for the inaugural Western Roses CF Golf Tournament, in support of Cystic Fibrosis Canada.
Only good times will be had!Read More
Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.
Every year, researchers and teams of investigators working in hospitals, universities, and research institutes across Canada apply for funding from our organization. They seek support for a variety of cystic fibrosis research projects – from basic lab research to support for clinical trials to studies on quality of life and drug discovery.
The pursuit of excellence through the rigorous peer review of all applications is the cornerstone of all Cystic Fibrosis Canada’s funding decisions, and is essential for fulfilling Cystic Fibrosis Canada’s mission. An excellent scientific review process substantially enhances the overall CF research effort, leading to a major beneficial impact on individuals affected by cystic fibrosis, and ensures research with the greatest potential to treat, manage or cure CF receives funding.
No scientist is likely to have sufficient expertise to be able to review all applications. For this reason, Cystic Fibrosis Canada recruits reviewers with different scientific backgrounds, so that they may review applications that reflect their individual areas of expertise. Applicants receive feedback following the review process to help them best assess their strengths and weaknesses and allow them to make improvements in future applications. Cystic Fibrosis Canada takes conflicts of interest between reviewers and applicants very seriously and has enacted measures to address such occurrences. In addition to the scientific reviewers, stakeholder representatives, who are often patients or parents of a child with CF, serve on the review panel and provide an outlook based on their unique and personal life experiences.
The recommendations of the peer review panel, together with a statement of the budget implications, are presented to Cystic Fibrosis Canada’s Board of Directors. The Board is then responsible for the final decisions of Cystic Fibrosis Canada regarding all research policies and funding.